ICOPE Program Feasibility in the Management of Myeloma Patients
Recruiting
N/A
Interventional Study
Frailty
Multiple Myeloma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 70 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 30 (estimated)
- Sponsor
- University Hospital, Toulouse · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female aged over 70 years,
* Patient with multiple myeloma
* WHO performance status 0-3,
* Patient eligible for first- or second-line treatment
* Patient willing to participate in ICOPE MONITOR program
* Patient or caregiver able to use digital tools of ICOPE MONITOR: …
Contacts